TOIIW

The Oncology Institute, Inc. Warrant

0.0900 USD
+0.0296
49.01%
At close May 19, 4:00 PM EDT
1 day
49.01%
5 days
28.76%
1 month
157.14%
3 months
181.25%
6 months
643.80%
Year to date
857.45%
1 year
103.16%
5 years
-96.37%
10 years
-96.37%
 

About: The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Employees: 825

0
Funds holding %
of 7,202 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

394% more capital invested

Capital invested by funds: $19.2K [Q4 2024] → $94.9K (+$75.7K) [Q1 2025]

0.13% less ownership

Funds ownership: 4.78% [Q4 2024] → 4.65% (-0.13%) [Q1 2025]

21% less funds holding

Funds holding: 14 [Q4 2024] → 11 (-3) [Q1 2025]

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Research analyst outlook

We haven’t received any recent analyst ratings for TOIIW.

Financial journalist opinion

We haven’t received any recent news articles for TOIIW.

Charts implemented using Lightweight Charts™